Page results
-
UCLH is to work in partnership with University Hospitals Birmingham NHS Foundation Trust in a major digital health initiative in which researchers use data collected in acute care settings to improve patient care.
-
Initial results from an early phase study testing the safety and efficacy of a new drug for multiple myeloma have shown a 100 per cent overall response rate in patients with recurrent disease who were given the clinically recommended dose of the investigational drug.
-
UCLH has opened a new vaccine research centre with two clinical trials testing a long-acting antibody combination treatment to protect against Covid-19.
-
This page explains what you can expect after you have been referred to the Lymphoedema Service at University College London Hospitals (UCLH) for a video or telephone appointment.
-
A world-first treatment for Creutzfeldt-Jakob disease (CJD) has shown “very encouraging” early results following its use in six patients at University College London Hospitals (UCLH) NHS Foundation Trust.
-
The Neurorehabilitation Unit (NRU) at The National Hospital for Neurology and Neurosurgery (NHNN) has been refurbished with funding from The National Brain Appeal to provide new facilities and additional space, transforming it into a more therapeutic environment.
-
Today, this National Day of Reflection, we remember those members of staff who we sadly lost due to COVID-19.
-
Information about the new government support available to help people pay their energy bills.
-
This page is for parents, carers and family members who are acting as comforters and carers for children and young people having radioactive iodine (131I) treatment. It explains what the treatment involves, how to prepare for it and what you can expect afterwards.
-
Information for patients (or anyone who is involved in their care) who have undergone implantation of an Intrathecal Baclofen Pump under the care of the team at this hospital.
File results
-
FOI/2023/0665 - Trust pathology services
-
FOI/2023/0670 - Treatment with immunomodulatory medications
-
FOI/2023/0672 - Treatment with dermatology and respiratory medicine
-
FOI/2023/0675 - Number of cancer treatments at each stage
-
FOI/2023/0681 - Patient friends and family test supplier
-
FOI/2023/0683 - Electronic Patient Records (EPR)/ Patient Administration System (PAS)
-
FOI/2023/0686 - Hysteroscopy Inpatient and Outpatient pathways
-
FOI/2023/0687 - Information Governance pay grades
-
FOI/2023/0689 - Access to digital test results for patients
-
FOI/2023/0691 - Integrated medicine